Imaging in head and neck cancer

Current Treatment Options in Oncology

Volumn 7, Issue 1, 2006, Pages 23-34

  Rumboldt, Zoran ^a   Gordon, Leonie ^b   Bonsall, Rick ^b   Ackermann, Susan ^b  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

FLUORODEOXYGLUCOSE; IODINE 123; PERTECHNETIC ACID TC 99M; RADIOACTIVE IODINE; SUPERPARAMAGNETIC IRON OXIDE;

ADVANCED CANCER; ASPIRATION BIOPSY; BONE MARROW; BREATHING; CANCER CONTROL; CANCER STAGING; COMPUTER ASSISTED TOMOGRAPHY; FALSE NEGATIVE RESULT; FALSE POSITIVE RESULT; HEAD AND NECK CANCER; HUMAN; HYPOPHARYNX CANCER; IMAGE ANALYSIS; LARYNX CANCER; LYMPH NODE METASTASIS; LYMPHADENOPATHY; METASTASIS POTENTIAL; MOUTH CANCER; NASOPHARYNX CANCER; NUCLEAR MAGNETIC RESONANCE IMAGING; OROPHARYNX CANCER; PAROTID GLAND TUMOR; PERINEURIUM; POSITRON EMISSION TOMOGRAPHY; PROGNOSIS; RECURRENT CANCER; REVIEW; SALIVARY GLAND CANCER; SENSITIVITY AND SPECIFICITY; SWALLOWING; THYROID CANCER; TONGUE CANCER; TUMOR BIOPSY; TUMOR VOLUME;

BIOPSY; HEAD AND NECK NEOPLASMS; HUMANS; LYMPHATIC METASTASIS; MAGNETIC RESONANCE IMAGING; NEOPLASM STAGING; POSITRON-EMISSION TOMOGRAPHY; TOMOGRAPHY, X-RAY COMPUTED;

EID: 31344468808     PISSN: 15272729     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11864-006-0029-2     Document Type: Review

References (60)

1. Chong VF, Mukherji SK, Ng SH, et al.: Nasopharyngeal carcinoma: review of how imaging affects staging. J Comput Assist Tomogr 1999, 23:984-993.
2. Sakata K, Hareyama M, Tamakawa M, et al.: Prognostic factors of nasopharynx tumors investigated by MR imaging and the value of MR imaging in the newly published TNM staging. Int J Radiat Oncol Biol Phys 1999, 43:273-278.
3. Rumboldt Z, Castillo M, Smith JK: The palatovaginal canal: can it be identified on routine CT and MRI studies? Am J Roentgenol 2002, 179:267-272.
4. Mukherji SK, Schmalfuss IM, Castelijns J, Mancuso AA: Clinical applications of tumor volume measurements for predicting outcome in patients with squamous cell carcinoma of the upper aerodigestive tract. Am J Neuroradiol 2004, 25:1425-1432.
5. Mukherji SK, Isaacs DL, Creager A, et al.: CT detection of mandibular invasion by squamous cell carcinoma of the oral cavity. Am J Roentgenol 2001, 177:237-243.
6. Lam P, Au-Yeung KM, Cheng PW, et al.: Correlating MRI and histologic tumor thickness in the assessment of oral tongue cancer. Am J Roentgenol 2004, 182:803-808.
7. Curtin D: Detection of perineural spread: fat suppression versus no fat suppression. Am J Neuroradiol 2004, 25:1-3.
8. Bolzoni A, Cappiello J, Piazza C, et al.: Diagnostic accuracy of magnetic resonance imaging in the assessment of mandibular involvement in oral-oropharyngeal squamous cell carcinoma: a prospective study. Arch Otolaryngol Head Neck Surg 2004, 130:837-843.
9. Weissman JL, Carrau RL: "Puffed-cheek" CT improves evaluation of the oral cavity. Am J Neuroradiol 2001, 22:741-744.
10. Hsu WC, Loevner LA, Karpati R, et al.: Accuracy of magnetic resonance imaging in predicting absence of fixation of head and neck cancer to the prevertebral space. Head Neck 2005, 27:95-100.
11. Becker M: Neoplastic invasion of laryngeal cartilage: radiologic diagnosis and therapeutic implications. Eur J Radiol 2000, 33:216-229.
12. Becker M, Zbaren P, Delavelle J, et al.: Neoplastic invasion of the laryngeal cartilage: reassessment of criteria for diagnosis at CT. Radiology 1997, 203:521-532.
13. Thoeny HC, Delaere PR, Hermans R: Correlation of local outcome after partial laryngectomy with cartilage abnormalities on CT. Am J Neuroradiol 2005, 26:674-678.
14. Zbaren P, Becker M, Lang H: Pretherapeutic staging of laryngeal carcinoma. Clinical findings, computed tomography, and magnetic resonance imaging compared with histopathology. Cancer 1996, 77:1263-1273.
15. Hermans R, Van den Bogaert W, Rijnders A, et al.: Predicting the local control of glottic squamous cell carcinoma after definitive radiation therapy: value of computed tomography-determined tumour parameters. Radiother Oncol 1999, 50:39-46.
16. Murakami R, Furusawa M, Baba Y, et al.: Dynamic helical CT of T1 and T2 glottic carcinomas: predictive value for local control with radiation therapy. Am J Neuroradiol 2000, 21:1320-1326.
17. Mancuso AA, Mukherji SK, Kotzur I, et al.: Preradiotherapy-computed tomography as a predictor of local control in supraglottic carcinoma. J Clin Oncol 1999, 17:631-636.
18. Ljumanovic R, Langendijk JA, Schenk B, et al.: Supraglottic carcinoma treated with curative radiation therapy: identification of prognostic groups with MR imaging. Radiology 2004, 232:440-448.
19. Roychowdhury S, Loevner LA, Yousem DM, et al.: MR imaging for predicting neoplastic invasion of the cervical esophagus. Am J Neuroradiol 2000, 21:1681-1687.
20. Wildi SM, Fickling WE, Day TA, et al.: Endoscopic ultrasonography in the diagnosis and staging of neoplasms of the head and neck. Endoscopy 2004, 36:624-630.
21. Magnano M, Bongioannini G, Cirillo S, et al.: Virtual endoscopy of laryngeal carcinoma: is it useful? Otolaryngol Head Neck Surg 2005, 132:776-782.
22. Maroldi R, Farina D, Palvarini L, et al.: Magnetic resonance imaging findings of inverted papilloma: differential diagnosis with malignant sinonasal tumors. Am J Rhinol 2004, 18:305-310.
23. Loevner LA, Sonners AI: Imaging of neoplasms of the paranasal sinuses. Magn Reson Imaging Clin N Am 2002, 10:467-493.
24. Eisen MD, Yousem DM, Loevner LA, et al.: Preoperative imaging to predict orbital invasion by tumor. Head Neck 2000, 22:456-462.
25. Hamilton BE, Salzman KL, Wiggins RH 3rd, Harnsberger HR: Earring lesions of the parotid tail. Am J Neuroradiol 2003, 24:1757-1764.
26. Sakamoto M, Sasano T, Higano S, et al.: Usefulness of heavily T2-weighted magnetic resonance images for the differential diagnosis of parotid tumours. Dentomaxillofac Radiol 2003, 32:295-299.
27. Shah GV: MR imaging of salivary glands. Magn Reson Imaging Clin N Am 2002, 10:631-662.
28. Habermann CR, Gossrau P, Graessner J, et al.: Diffusion-weighted echo-planar MRI: a valuable tool for differentiating primary parotid gland tumors? Rofo 2005, 177:940-945.
29. Divi V, Fatt MA, Teknos TN, Mukherji SK: Use of cross-sectional imaging in predicting surgical location of parotid neoplasms. J Comput Assist Tomogr 2005, 29:315-319.
30. Schmalfuss IM, Tart RP, Mukherji S, Mancuso AA: Perineural tumor spread along the auriculotemporal nerve. Am J Neuroradiol 2002, 23:303-311.
31. Kaylie DM, Wax MK, Weissman JL: Preoperative facial muscle imaging predicts final facial function after facial nerve grafting. Am J Neuroradiol 2003, 24:326-330.
32. Ross D: Nonpalpable thyroid nodule: managing an epidemic. J Clin Endocrinol Metab 2002, 87:1938-1940.
33. Kim EK, Park CS, Chung WY, et al.: New sonographic criteria for recommending fine-needle aspiration biopsy of nonpalpable solid nodules of the thyroid. Am J Roentgenol 2002, 178:687-691.
34. Meller J, Becker W: The continuing importance of thyroid scintigraphy in the era of high resolution ultrasound. Euro J Nuc Med 2002, 29:425-438.
35. Wang J, Takashima S, Matsushita T, et al.: Esophageal invasion by thyroid carcinomas: prediction using magnetic resonance imaging. J Comput Assist Tomogr 2003, 27:18-25.
36. Takashima S, Takayama F, Wang J, et al.: Using MR imaging to predict invasion of the recurrent laryngeal nerve by thyroid carcinoma. AJR Am J Roentgenol 2003, 180:837-842.
37. Hao SP, Ng SH: Magnetic resonance imaging versus clinical palpation in evaluating cervical metastasis from head and neck cancer. Otolaryngol Head Neck Surg 2000, 123:324-327.
38. King AD, Tse GM, Ahuja AT, et al.: Necrosis in metastatic neck nodes: diagnostic accuracy of CT, MR imaging, and US. Radiology 2004, 230:720-726.
39. Screaton NJ, Berman LH, Grant JW: Head and neck lymphadenopathy: evaluation with US-guided cutting-needle biopsy. Radiology 2002, 224:75-81.
40. Anzai Y: Superparamagnetic iron oxide nanoparticles: nodal metastases and beyond. Top Magn Reson Imaging 2004, 15:103-111.
41. Adams S, Baum RP, Stuckensen T, et al.: Prospective comparison of 18F-FDG PET with conventional imaging modalities (CT, MRI, US) in lymph node staging of head and neck cancer. Eur J Nucl Med 1998, 25:1255-1260.
42. Hart RD, Nasse JG, Trites JR, et al.: Sentinel lymph node biopsy in N0 squamous cell carcinoma of the oral cavity and oropharynx. Arch Otolaryngol Head Neck Surg 2005, 131:34-38.
43. Ginsberg LE: MR imaging of perineural tumor spread. Neuroimaging Clin N Am 2004, 14:663-677.
44. Nemzek WR, Hecht S, Gandour-Edwards R, et al.: Perineural spread of head and neck tumors: how accurate is MR imaging? Am J Neuroradiol 1998, 19:701-706.
45. Yu Q, Wang P, Shi H, Luo J: Carotid artery and jugular vein invasion of oral-maxillofacial and neck malignant tumors: diagnostic value of computed tomography. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2003, 96:368-372.
46. Yousem DM, Hatabu H, Hurst RW, et al.: Carotid artery invasion by head and neck masses: prediction with MR imaging. Radiology 1995, 195:715-720.
47. Mukherji SK, Toledano AY, Beldon C, et al.: Interobserver reliability of computed tomography-derived primary tumor volume measurement in patients with supraglottic carcinoma. Cancer 2005, 103:2616-2622.
48. Gordon AR, Loevner LA, Shukla-Dave A, et al.: Intraobserver variability in the MR determination of tumor volume in squamous cell carcinoma of the pharynx. Am J Neuroradiol 2004, 25:1092-1098.
49. Schoder H, Yeung HW, Gonen M, et al.: Head and neck cancer: clinical usefulness and accuracy of PET/CT image fusion. Radiology 2004, 231:65-72.
50. Branstetter BF 4th, Blodgett TM, Zimmer LA, et al.: Head and neck malignancy: is PET/CT more accurate than PET or CT alone? Radiology 2005, 235:580-586.
51. Kapoor V, Fukui MB, McCook BM: Role of 18F FDG PET/CT in the treatment of head and neck cancers: principles, technique, normal distribution, and initial staging. Am J Roentgenol 2005, 184:579-587.
52. Brun E, Kjellen E, Tennvall J, et al.: FDG PET studies during treatment: prediction of therapy outcome in head and neck squamous cell carcinoma. Head Neck 2002, 24:127-135.
53. Fogarty GB, Peters LJ, Stewart J, et al.: The usefulness of fluorine 18-labelled deoxyglucose positron emission tomography in the investigation of patients with cervical lymphadenopathy from an unknown primary tumor. Head Neck 2003, 25:138-145.
54. Kapoor V, Fukui MB, McCook BM: Role of 18F FDG PET/CT in the treatment of head and neck cancers: posttherapy evaluation and pitfalls. Am J Roentgenol 2005, 184:589-597.
55. Rumboldt Z, Al-Okaili R, Roberts D, Deveikis J: Perfusion CT for head and neck tumors: pilot study. Am J Neuroradiol 2005, 26:1178-1185.
56. Sherman PM, Yousem DM, Loevner LA: CT-guided aspirations in the head and neck: assessment of the first 216 cases. Am J Neuroradiol 2004, 25:1603-1607.
57. Titton RL, Gervais DA, Boland GW, et al.: Sonography and sonographically guided fine-needle aspiration biopsy of the thyroid gland: indications and techniques, pearls and pitfalls. Am J Roentgenol 2003, 181:267-271.
58. Som PM, Silvers AR, Urken ML: Surveillance CT and the prompt use of CT-guided fine-needle aspiration in patients with head and neck cancer who have undergone surgery. Am J Roentgenol 1999, 173:1505-1508.
59. Loevner LA, Sonners AI, Schulman BJ, et al.: Reinterpretation of cross-sectional images in patients with head and neck cancer in the setting of a multidisciplinary cancer center. Am J Neuroradiol 2002, 23:1622-1626.
60. Ginsberg LE: Reinterpretation of head and neck scans: massive can of worms or call to action? Am J Neuroradiol 2002, 23:1617-1618.